Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 272

Similar articles for PubMed (Select 9989567)

1.

Diazepam treatment of early signs of exacerbation in schizophrenia.

Carpenter WT Jr, Buchanan RW, Kirkpatrick B, Breier AF.

Am J Psychiatry. 1999 Feb;156(2):299-303.

PMID:
9989567
2.

Fluphenazine vs placebo supplementation for prodromal signs of relapse in schizophrenia.

Marder SR, Wirshing WC, Van Putten T, Mintz J, McKenzie J, Johnston-Cronk K, Lebell M, Liberman RP.

Arch Gen Psychiatry. 1994 Apr;51(4):280-7.

PMID:
8161288
3.

Sarcosine or D-serine add-on treatment for acute exacerbation of schizophrenia: a randomized, double-blind, placebo-controlled study.

Lane HY, Chang YC, Liu YC, Chiu CC, Tsai GE.

Arch Gen Psychiatry. 2005 Nov;62(11):1196-204.

PMID:
16275807
4.

A post hoc analysis of the impact on hostility and agitation of quetiapine and haloperidol among patients with schizophrenia.

Chengappa KN, Goldstein JM, Greenwood M, John V, Levine J.

Clin Ther. 2003 Feb;25(2):530-41.

PMID:
12749512
5.

Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.

Woods SW, Gueorguieva RV, Baker CB, Makuch RW.

Arch Gen Psychiatry. 2005 Sep;62(9):961-70. Review.

PMID:
16143728
6.

Combination alprazolam-neuroleptic treatment of the positive and negative symptoms of schizophrenia.

Wolkowitz OM, Pickar D, Doran AR, Breier A, Tarell J, Paul SM.

Am J Psychiatry. 1986 Jan;143(1):85-7.

PMID:
2867690
7.

A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia.

Breier A, Meehan K, Birkett M, David S, Ferchland I, Sutton V, Taylor CC, Palmer R, Dossenbach M, Kiesler G, Brook S, Wright P.

Arch Gen Psychiatry. 2002 May;59(5):441-8.

PMID:
11982448
8.

A double-blind controlled study of adjunctive treatment with risperidone in schizophrenic patients partially responsive to clozapine: efficacy and safety.

Anil Yağcioğlu AE, Kivircik Akdede BB, Turgut TI, Tümüklü M, Yazici MK, Alptekin K, Ertuğrul A, Jayathilake K, Göğüş A, Tunca Z, Meltzer HY.

J Clin Psychiatry. 2005 Jan;66(1):63-72.

PMID:
15669890
11.

Double-blind, randomized comparison of olanzapine versus fluphenazine in the long-term treatment of schizophrenia.

Dossenbach MR, Folnegovic-Smalc V, Hotujac L, Uglesic B, Tollefson GD, Grundy SL, Friedel P, Jakovljevic MM; Olanzapine HGCH Study Group.

Prog Neuropsychopharmacol Biol Psychiatry. 2004 Mar;28(2):311-8.

PMID:
14751428
12.

Dehydroepiandrosterone augmentation in the management of negative, depressive, and anxiety symptoms in schizophrenia.

Strous RD, Maayan R, Lapidus R, Stryjer R, Lustig M, Kotler M, Weizman A.

Arch Gen Psychiatry. 2003 Feb;60(2):133-41.

PMID:
12578430
13.

Efficacy and safety of bifeprunox in patients with an acute exacerbation of schizophrenia: results from a randomized, double-blind, placebo-controlled, multicenter, dose-finding study.

Casey DE, Sands EE, Heisterberg J, Yang HM.

Psychopharmacology (Berl). 2008 Oct;200(3):317-31. doi: 10.1007/s00213-008-1207-7. Epub 2008 Jul 4.

PMID:
18597078
14.

Clozapine augmented with risperidone in the treatment of schizophrenia: a randomized, double-blind, placebo-controlled trial.

Josiassen RC, Joseph A, Kohegyi E, Stokes S, Dadvand M, Paing WW, Shaughnessy RA.

Am J Psychiatry. 2005 Jan;162(1):130-6.

PMID:
15625211
15.

Risperidone in treatment-refractory schizophrenia.

Wirshing DA, Marshall BD Jr, Green MF, Mintz J, Marder SR, Wirshing WC.

Am J Psychiatry. 1999 Sep;156(9):1374-9.

PMID:
10484947
16.
17.

Placebo-controlled trial of glycine added to clozapine in schizophrenia.

Evins AE, Fitzgerald SM, Wine L, Rosselli R, Goff DC.

Am J Psychiatry. 2000 May;157(5):826-8.

PMID:
10784481
18.
19.

Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis.

McGlashan TH, Zipursky RB, Perkins D, Addington J, Miller T, Woods SW, Hawkins KA, Hoffman RE, Preda A, Epstein I, Addington D, Lindborg S, Trzaskoma Q, Tohen M, Breier A.

Am J Psychiatry. 2006 May;163(5):790-9.

PMID:
16648318
20.

Olanzapine versus ziprasidone: results of a 28-week double-blind study in patients with schizophrenia.

Breier A, Berg PH, Thakore JH, Naber D, Gattaz WF, Cavazzoni P, Walker DJ, Roychowdhury SM, Kane JM.

Am J Psychiatry. 2005 Oct;162(10):1879-87.

PMID:
16199834
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk